The pharmaceutical industry faces an unprecedented threat from counterfeit medications, representing one of the most dangerous and rapidly growing criminal enterprises worldwide. Pharmaceutical counterfeiting is estimated to cost pharmaceutical companies billions of dollars annually worldwide, so the stakes are far higher than just financial gain; patient lives, legal requirements, and brand image are all on the line.
Counterfeit drugs are extremely dangerous and cause serious health problems, as they have wrong dosages, some are dangerous, or some may even have no active... >>More
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Nitin Stephen Abel, Senior Director - Terumo Interventional Systems, Terumo India
Nishi Sharma, Associate Vice President (Digital Governance), Alpha MD
Dheeraj Jain, Founder, Redcliffe Labs
Shweta Rai, Managing Director - India & Country Division Head - South Asia, Bayer Pharmaceuticals
Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre